{"paper_id":"e343ee5d-fc09-4430-a37a-77a9562ea765","body_text":"Chronic endometritis (CE) is a persistent inflammatory disease that is characterized by the\ninfiltration of plasma cells to the endometrial stroma \n 1 \n . Chronic endometritis is one of the major factors that account for the unexplained\ninfertility,  in vitro  fertilization (IVF) failure, and recurrent failure in\nearly pregnancy in women \n 2 \n . Antibiotic therapy is commonly used for the treatment of CE, but its efficacy is\nunsatisfied. Therefore, developing novel strategies for the prevention and treatment of CE\nis still needed.\nMesenchymal stem cells (MSCs) are a group of adult tissue progenitor cells that have the\npotential of self-renewal and multilineage differentiation \n 3 \n . A recent study shows that transfer of endometrial mesenchymal stem cells (enMSCs)\nmeliorates CE and improves the repeated implantation failure \n 4 \n . Increasing evidence reveals that MSCs exert their function via transporting exosomes\n(Exos), extracellular vesicles, as well as cytokines to host cells \n 5 \n . Exos are nanovesicles secreted by different cell types, which transfer proteins,\nDNAs, and RNAs into the extracellular space and thus participate in a number of biological\nprocesses, such as cell survival, immunity, and inflammation 6 – 8 . The use of Exos avoids a number of shortcomings of stem cell therapy \n 9 \n  and thus is suggested to be an attractive approach for the treatment of multiple\ndiseases 10 , 11 .\nAdipose tissue–derived stem cells (ADSCs) are mesenchymal cells derived from adipose\ntissues, which possess the capacity of regenerative properties as MSCs \n 12 \n . A previous study reported that in dairy cows, treatment with bovine ADSCs inhibits\nlipopolysaccharide (LPS)-induced inflammation response via suppressing the levels of tumor\nnecrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) in\nendometrial epithelial cells \n 13 \n . Multiple studies have reported that Exos derived from ADSCs play a crucial role in\nthe inhibition of inflammatory activity 14 – 16 . However, the therapeutic effect of Exos derived from ADSCs (ADSC-Exos)\non CE remains unknown.\nIn this study, we sought to investigate the effect of ADSC-Exos on LPS-induced inflammation\nin endometrial cells both  in vitro  and  in vivo , and\nexplore the possible mechanisms underlying their action.\n\nHuman endometrial stromal cells (HESCs) and human ADSCs were obtained from the American\nType Culture Collection (ATCC, USA) and Cyagen Biology (Guangzhou, China), respectively.\nHuman endometrial stromal cells were cultured in Dulbecco’s Modified Eagle Medium\n(DMEM)/F12 (Thermo Fisher Scientific, Waltham, MA, USA), which contains 2% fetal bovine\nserum (FBS; Thermo Fisher Scientific) and 1% penicillin-streptomycin (Thermo Fisher\nScientific), while ADSCs were cultured in DMEM medium (Thermo Fisher Scientific) that\ncontains 10% FBS and 1% penicillin-streptomycin. Both HESCs and ADSCs were maintained at\n37°C in an incubator with 5% CO 2 .\nExosome extraction was carried out with the medium of ADSCs by ultracentrifugation. The\ncentrifugation of medium was performed as follows: 3,000 ×  g  for 15 min\nand then 20,000 ×  g  for 45 min at 4°C. The supernatant was collected and\nfiltered. Then, the supernatant was centrifuged again at 110,000 ×  g  for\n70 min at 4°C twice. The exosome pellet was resuspended with phosphate-buffered saline\n(PBS) and stored at −80°C for further experiments.\nTransmission electron microscopy was used to visualize the morphology of isolated Exos. A\ndrop of Exos in PBS solution was placed onto a copper grid. Exos were washed with PBS and\nthen fixed with glutaraldehyde solution (3%) for 15 min. After another wash with PBS, Exos\nwere incubated with uranyl acetate solution (2%) for 5 min. Finally, Exos were visualized\nusing a transmission electron microscope and the Exo size was measured using a dynamic\nlight scattering.\nTo analyze whether Exos could be taken up by HESCs, Exos were firstly labeled with KH67\nfluorescent dye (Sigma-Aldrich, St. Louis, MO, USA). Then, 2 μg KH67-labeled Exos were\nadded to HESCs that were cultured in 6-well plates. Twenty-four hours later, HESCs were\nfixed with 4% paraformaldehyde and stained with 4′,6-diamidino-2-phenylindole solution.\nThe staining of HESCs was examined using a confocal microscope (Carl Zeiss, Oberkochen,\nGermany).\nThe EdU (5-ethynyl-2′-deoxyuridine) staining assay was performed to detect the\nproliferation of HESCs. Human endometrial stromal cells (5 × 10 4 ) were seeded\nin a 24-well plate and cultured overnight. 500 ng/ml LPS (Sigma-Aldrich) and/or 1 μg Exos\nwere added onto HESCs. Twenty-four hours later, HESCs were washed with PBS once and\nstained with the BeyoClick™ EdU-488 Cell Proliferation Assay Kit (Beyotime, Shanghai,\nChina), according to the manufacturer’s instructions. DNA staining was performed with DAPI\nsolution. Human endometrial stromal cells were visualized using a fluorescence\nmicroscopy.\nTo detect the direct interaction between miR-21 and TLR4, luciferase reporter assay was\nconducted. TRL4 3′-untranslated region fragments with wild-type or mutant miR-21 binding\nsite were cloned into the luciferase reporter vector to construct TRL4 wild type\n3′-untranslated region or TRL4 MU 3′-untranslated region. Human endometrial stromal cells\nwere co-transfected with TRL4 wild type 3′-UTR (or TRL4 mutant 3′-untranslated region) and\nmiR-21 (or control miRNA) using the Lipofectamine 2000 reagent (Invitrogen, CA, USA).\nAfter transfection for 48 h, the firefly and renilla luciferase activity were detected\nwith the dual-luciferase reporter assay kit (Promega, Madison, WI, USA), according to the\nmanufacturer’s protocol.\nFlow cytometry was performed to analyze the apoptotic rate of HESCs. Human endometrial\nstromal cells (2.5 × 105 cells/well) were cultured in 6-well plates overnight before\ntreatment. Human endometrial stromal cells were treated with 500 ng/ml LPS alone or\ntogether with 1 μg Exos for 48 h. Then, the medium was removed and HESCs were collected.\nAfter centrifugation, the cell pellet was washed with PBS once. Staining of HESCs was\nconducted using the Annexin V-FITC apoptosis detection kit (BD, Franklin Lakes, NJ, USA)\nfollowing the manufacturer’s introduction. Stained cells were analyzed using the flow\ncytometer (BD Biosciences).\nCell Counting Kit-8 assay was carried out to determine the viability of HESCs. HESCs were\nseeded in a 96-well plate and treated with different concentrations of LPS (0–500 ng/ml)\nfor 48 h. At the indicated time point, 10 μl of Cell Counting Kit-8 solution (Seyotin,\nGuangzhou, China) was added to each well and the cells were incubated for 2–4 h. Finally,\nthe optical density (OD) at 450 nm was examined by a microplate reader (BioTek, Vermont,\nUSA).\nTotal RNA from HESCs or endometrial tissues was isolated using the Trizol reagent (Thermo\nFisher Scientific). Complementary DNA (cDNA) synthesis was performed with total RNA using\nthe Invitrogen TM Superscript III First-Strand Synthesis System (Seyotin). For the\ndetection of miR-21, cDNA was reversed using a TaqMan™ Advanced miRNA cDNA Synthesis Kit\n(Seyotin). Real-time polymerase chain reaction (PCR) was carried out using the PowerUp\nSYBR Green PCR Master Mix (Seyotin). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was\nused as an internal control for mRNA expression and U6 was used as an internal control of\nmiR-21 expression. Relative gene expression levels were measured using a 2 –ΔΔCT \nformula. The primers used were as follows: TLR4-F, ACTTGGACCTTTCCAGCAAC and TLR4-R,\nTTTAAATGCACCTGGTTGGA; TNF-α-F, TGACGGGCTTTACCTCATCT and TNF-α-R, TGATGGCAGACAGG ATGTTG;\nIL-6-F, AACGAGTGGGTAAAGAACGC and IL-6-R, CTGACCAGA GGAGGGAATGC; β-actin-F,\nCCAAGGCCAACCGTGA GAAAAT and β-actin-R, CCACATTCCGTGAGGATCTTCA; IL-1β-F, ATGAAG\nAGCTGCATCCAACA and IL-1β-R, ATGGAAGACATGTGCGTAGG.\nHESCs and Exos were collected, washed with PBS, and lysed in radioimmunoprecipitation\nassay (RIPA) lysis buffer. The concentration of different samples was detected by the\nbicinchoninic acid method. The protein sample was separated by 10% sodium dodecyl\nsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gel, followed by transfer onto a\npolyvinylidene fluoride (PVDF) membrane (Seyotin). The membrane was incubated with TBST\n(TBS-Tween 20) solution containing 5% non-fat milk for 1 h at room temperature. Then, the\nmembrane was incubated with primary antibodies at 4°C overnight. On the next day, the\nmembrane was washed three times with PBS and incubated with horseradish peroxidase\n(HRP)-conjugated secondary antibodies for 90 min at room temperature. Protein bands were\nvisualized using the ECL Western Blotting Substrate (Seyotin). The used antibodies were as\nfollows: CD9, 1:1,000, ab92726, Abcam; CD63, 1:1,000, ab134045, Abcam; TNF-α, 1:1,000,\n17590-1-AP, Proteintech; IL-1β1:1,000, #12242, Cell Signaling Technology; IL-6, 1:1,000,\nab6672, Abcam; GAPDH 1:2,000, 60004-1-Ig, Proteintech; TLR4, 1:1,000, ab13556, Abcam;\np-p65, 1:1,000, #3033, Cell Signaling Technology; p65, 1:1,000, #8242, Cell Signaling\nTechnology.\nPCDNA3.1-Myc-TLR4 overexpressing plasmid was purchased from Genecopoeia. DNA transfection\nwas carried out using the Lipofectamine™ 3000 reagent (Thermo Fisher Scientific).\nA CE mouse model was established to detect the function of Exos in the inflammation\nresponse  in vivo . Kunming female mice (8–10 weeks old, 25–30 g) were\npurchased from the Chinese Academy of Sciences (Beijing, China) and cultured under a 12 h\nlight/12 h dark cycle. The mice were randomly divided into three groups with 10 mice per\ngroup (control, LPS, and Exos). The control group received 20 μl of PBS by uterine\nperfusion, while the LPS group received 20 μl of LPS (2.5 μg/μl). Twelve hours\npost-perfusion, mice in the control and LPS groups were intraperitoneally injected with 20\nμl of PBS, and mice in the Exos group were intraperitoneally injected with 20 μg of\nexosomes. Twelve hours later, mice were sacrificed and the uteri were isolated for further\nexperiments. All animal procedures were conducted according to the animal guidelines\napproved by the Institutional Animal Care and Use Committee of Daoke Medical Technology\n(Guangdong) Co., LTD.\nMouse endometrial tissues were fixed in 10% buffered formalin and embedded in paraffin.\nParaffin-embedded tissues were cut into 4-μm-thick sections. Sections were then dewaxed,\ndehydrated, and antigen-retrieved in citrate buffer. After blocking in 5% bovine serum\nalbumin, sections were probed with TNF-α, IL-1β, and IL-6 antibodies. Sections were washed\nthree times with PBS and incubated with biotinylated secondary antibody. After three\nwashes with PBS, sections were incubated with HRP-conjugated streptavidin (Thermo Fisher\nScientific), followed by incubation with diaminobenzidine solution. Sections were\ncounterstained with hematoxylin.\nData were represented as mean ± standard deviation (SD). Statistical analysis was carried\nout using the SPSS 15.0 software (SPSS, USA). Comparisons among different groups were\naccessed by one-way analysis of variance (ANOVA). Values of  P  < 0.05\nwere considered statistically significant.\n\nExos were isolated by ultracentrifugation using the supernatant of ADSCs. The morphology\nof Exos was analyzed using transmission electron microscopy and a spherical morphology was\ndetected ( Fig. 1A ). The mean size\ndistribution of Exos was 118.9 nm ( Fig.\n1B ). Western blot was performed to detect the exosome makers, CD9 and CD63. As\nshown in  Fig. 1C , in comparison\nwith the control cells, the expressions of CD9 and CD63 were highly increased in Exos. We\nthen investigated whether Exos could be taken up by HESCs. Exos labeled with PKH67 green\nfluorescent dye was incubated with HESCs for 24 h and immunofluorescence staining was\nperformed. As shown in  Fig. 1D ,\ngreen fluorescent spots were observed in HESCs, indicating that Exos were internalized by\nHESCs.\nCharacterization of isolated exosomes (Exos) from ADSCs. (A) The morphology of Exos\nwas detected by TEM analysis. (B) Size distribution of Exos was indicated by\nintensity. (C) The expression of exosome markers was analyzed by Western blot. (D) The\nuptake of Exos by HESCs was accessed by immunofluorescence staining. ADSCs: adipose\ntissue–derived stem cells; HESCs: human endometrial stromal cells; TEM: transmission\nelectron microscopy; DAPI:4’,6-diamidino-2-phenylindole.\nTo detect the function of Exos in CE, an  in vitro  CE model was\nestablished by treating HESCs with LPS. The results showed that treatment with LPS reduced\nthe proliferation of HESCs ( Supplemental Fig. S1A ) and induced the expression of inflammatory factors,\nsuch as IL-1β, IL-6, and TNF-α ( Supplemental Fig. S1B and C ). Interestingly, administration of Exos restored\nthe viability of HESCs inhibited by LPS ( Fig. 2A ). Moreover, while LPS increased the apoptosis of HESCs, treatment with\nExos blocked this effect ( Fig.\n2B , C). In addition, cocultured with Exos decreased the mRNA and protein levels of\nIL-1β, IL-6, and TNF-α that were induced by LPS in HESCs (Fig. 2D–G). Together, these\nresults indicate that Exos suppress LPS-mediated inflammation and increase HESC cell\nproliferation.\nExos inhibit the LPS-induced inflammatory response in HESCs. (A) HESC proliferation\nwas detected by EdU staining following treatment with LPS alone or together with Exos.\n(B) Apoptotic rate of HESCs was determined by flow cytometry following treatment with\nLPS alone or together with Exos. (C) The expression of apoptosis-related proteins in\nHESCs after treatment with LPS alone or together with Exos. (D–F) The mRNA expressions\nof IL-1β (D), IL-6 (E), and TNF-α (F) were detected by qRT-PCR in HESCs following\ntreatment with LPS alone or together with Exos. (G) The protein expression of TNF-α,\nIL-6, and IL-1β was detected by Western blot in HESCs following treatment with LPS\nalone or together with Exos. LPS: lipopolysaccharide; HESCs: human endometrial stromal\ncells; EdU: 5-ethynyl-2′-deoxyuridine; IL-1β: interleukin-1β; IL-6: interleukin-6;\nTNF-α: tumor necrosis factor-alpha; qRT-PCR: quantitative real-time polymerase chain\nreaction; GAPDH: glyceraldehyde-3-phosphate dehydrogenase;\nDAPI:4’,6-diamidino-2-phenylindole.\nmiR-21 has been reported to be involved in LPS-induced inflammatory response in endometrium \n 17 \n . Therefore, we investigated whether miRNA-21 contributed to the inhibitory effect\nof Exos on inflammation in our model. Quantitative real-time polymerase chain reaction\nanalysis showed that while LPS reduced the expression of miR-21 in HESCs, treatment with\nExos restored the level of miR-21 ( Fig.\n3A ). To confirm the function of miR-21 in HESCs, EdU staining assay was carried\nout. The result displayed that the number of EdU-positive cells was markedly decreased\nafter treatment with LPS, and this effect was counteracted by miR-21 ( Fig. 3B ). Lipopolysaccharide increased BAX\nexpression and decreased BCl-2 expression in HESCs, but these effects were reversed by\nmiR-21 ( Fig. 3C ), indicating that\nmiR-21 could repress LPS-induced HESC apoptosis. Moreover, overexpression of miR-21\ndecreased the levels of inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, that were\nelevated by LPS exposure ( Fig.\n3D , E). Overall, these data indicate that Exos suppress LPS-stimulated inflammation\nresponse and enhance HESC cell proliferation via miR-21.\nExos suppress LPS-stimulated inflammatory response via miR-21. (A) The expression of\nmiR-21 in HESCs was detected by qRT-PCR after treatment with LPS alone or together\nwith Exos. (B) The proliferation of HESCs was determined by EdU staining after\ntreatment with LPS alone or together with miR-21. (C) The expression of\napoptosis-associated proteins Bcl-2 and Bax was determined by Western blot after\ntreatment with LPS alone or together with miR-21. (D) The mRNA expression of TNF-α,\nIL-6 and IL-1β was determined by qRT-PCR after treatment with LPS alone or together\nwith miR-21. (E) The mRNA expression of TNF-α, IL-6, and IL-1β was determined by\nWestern blot after treatment with LPS alone or together with miR-21. LPS:\nlipopolysaccharide; HESCs: human endometrial stromal cells; qRT-PCR: quantitative\nreal-time polymerase chain reaction; EdU: 5-ethynyl-2′-deoxyuridine; TNF-α: tumor\nnecrosis factor-alpha; IL-6: interleukin-6; IL-1β: interleukin-1β; GAPDH:\nglyceraldehyde-3-phosphate dehydrogenase; DAPI:4’,6-diamidino-2-phenylindole;\nNC:negative control.\nIt is well known that TLR4 plays a key role in inflammation. TargetScan analysis revealed\nthat there was a miR-21-binding site in TLR4 3′-UTR ( Fig. 4A ). The luciferase reporter assay further\nconfirmed that TLR4 was a direct target of miR-21 in HESCs ( Fig. 4B ), which was consistent with previous studies\nin other cell types 18 – 20 . Moreover, overexpression of miR-21\ncould effectively reduce TLR4 expression ( Supplemental Fig. S2 ). As shown in  Fig. 4C , LPS increased TLR4 expression in HESCs, and\nthis effect was counteracted by Exo treatment. In agreement with this result,\nadministration of Exos decreased the phosphorylation of p65, a downstream effector of\nTLR4, but not the total protein of p65 ( Fig. 4C ). In addition, while Exos reduced LPS-induced production of TNF-α, IL-6,\nand IL-1β, overexpression of TLR4 abolished this effect ( Fig. 4D , E). Therefore, our data suggest that Exos\nsuppress LPS-induced inflammation via miR-21/TLR4/NF-κB signaling in HESCs.\nExos inhibit LPS-induced inflammatory response via miR-21/TLR4/NF-κB signaling. (A)\nThe potential binding site of miR-21 in TLR-4 3′-UTR was detected by TargetScan. (B)\nThe binding of miR-21 and TLR-4 3′-UTR was examined by dual-luciferase reporter assay.\n(C) The expression levels of TLR4, p65, and p-p65 were examined by Western blot after\nadministration of LPS alone or together with Exos. (D) Overexpression of TLR4 reversed\nthe effect of Exos on LPS-induced mRNA expression of TNF-α, IL-6, and IL-1β in HESC.\n(E) Overexpression of TLR4 reversed the effect of Exos on LPS-induced protein\nexpression of TNF-α, IL-6, and IL-1β in HESCs. LPS: lipopolysaccharide; TNF-α: tumor\nnecrosis factor-alpha; IL-6: interleukin-6; IL-1β: interleukin-1β; HESCs: human\nendometrial stromal cells; GAPDH: glyceraldehyde-3-phosphate dehydrogenase;\nTLR4:Toll-like receptor4; NF-KB:Nuclear factor kappa beta; UTR:Untranslated Region;\nWT:wild type; MU:mutant; OE:overexpression.\nTo verify the effect of Exos on inflammatory activity, a CE mouse model was utilized.\nImmunohistochemistry staining showed that the content of TNF-α, IL-6, and IL-1β was\nsignificantly elevated in endometrial tissues of LPS-treated mice compared with the\ncontrol mice. However, co-administration of Exos reduced the production of these\ninflammatory factors that were stimulated by LPS in endometrial tissues ( Fig. 5A ). Consistently, qRT-PCR and\nWestern blot validated that LPS induction markedly increased the mRNA and protein levels\nof TNF-α, IL-6, and IL-1β, which was blocked by Exos in mouse endometrial tissues ( Fig. 5B , C). Collectively, these\nresults indicate that Exos have a protective activity against endometrial inflammation\n in vivo .\nExos repress LPS-triggered inflammatory response  in vivo . (A) The\nprotein levels of TNF-α, IL-6, and IL-1β in mouse endometrial tissues were detected by\nimmunohistochemical staining. (B) The mRNA levels of TNF-α, IL-6, and IL-1β in mouse\nendometrial tissues were detected by qRT-PCR. (C) The protein levels of TNF-α, IL-6,\nand IL-1β in mouse endometrial tissues were detected by Western blot. LPS:\nlipopolysaccharide; TNF-α: tumor necrosis factor-alpha; IL-6: interleukin-6; IL-1β:\ninterleukin-1β; qRT-PCR: quantitative real-time polymerase chain reaction; GAPDH:\nglyceraldehyde-3-phosphate dehydrogenase.\n\nChronic endometritis is highly related to infertility in women. Hence, improving the\ntreatment of CE is of significant importance. In this study, we reported for the first time\nthat Exos derived from ADSCs had a suppressive effect on LPS-induced inflammation in\nendometrial cells and in a mouse model.\nExos are small vesicle secreted by different cell types, including ADSCs \n 9 \n . ADSC-Exos have attracted more and more attention as potential therapeutic agent \n 21 \n . ADSC-Exos have been reported to possess an anti-inflammatory activity. For example,\nZhao et al. \n 14 \n  report that Exos from ADSCs inhibit inflammation in white adipose tissue (WAT) of\ndiet-induced obese mice via activation of M2 macrophage polarization. Feng et al. \n 22 \n  show that treatment with ADSC-Exos decreases the production of inflammatory factors\nin microglia cells stimulated with LPS and thus prevent neuroinflammation. Chronic\nendometritis is an inflammation disease in the inner layer of uterine mucosa \n 23 \n , which is mainly caused by microbial infection in the uterine cavity \n 24 \n . Lipopolysaccharide is one of the important causes of endometritis \n 25 \n . Therefore, an  in vitro  endometritis model was established by\ntreating HESCs with LPS. Using this model, we found that treatment with ADSC-Exos\nsignificantly enhanced the proliferation of HESCs and inhibited HESC apoptosis. More\nimportantly, we found ADSC-Exos decreased the expression levels of IL-1β, TNF-α, and IL-6\nstimulated by LPS, indicating that ADSC-Exos had a protective activity against LPS-induced\ninflammation. Moreover, the anti-inflammatory activity of ADSC-Exos was also verified by a\nmouse model. Therefore, our data indicate that ADSC-Exos have a protective activity against\nLPS-induced inflammation in endometrial cells both  in vitro  and  in\nvivo .\nIt has been demonstrated that Exos can deliver different biomolecules to target cells to\nexert their function 6 – 8 . Among these cargo molecules, miRNAs have\nattracted great attention due to their extensive regulation in gene expression \n 26 \n . The function of miR-21 in inflammation modulation has been documented\npreviously 27 – 29 . It has been shown that in equine\nendometrium, the expression of miR-21 is markedly decreased after LPS challenge, indicating\nan involvement of miR-21 in inflammatory response in endometrium \n 17 \n . Consistently, our work showed that LPS exposure reduced the level of miR-21 in\nHESCs, whereas administration of ADSC-Exos restored the expression of miR-21. Moreover,\noverexpression of miR-21 caused downregulation of inflammatory cytokines, including IL-1β,\nTNF-α, and IL-6, and increased HESC proliferation. Therefore, our results suggest that\nmiR-21 plays an important role in ADSC-Exo-mediated suppression of inflammation\nresponse.\nToll-like receptor (TLR) is critical for the primary innate immune response to pathogenic challenge \n 30 \n . Studies from Ju et al. \n 31 \n  reveal that TLR4 plays a critical role in the pathogenesis of human CE. They found\nthat the expression of TLR4, as well as the levels of its corresponding downstream signaling\nfactors, such as p-p65, TNF-α, and IL-1β, is upregulated in CE tissues compared with normal\nendometrial tissues \n 31 \n . miR-21 has been shown to regulate TLR4 expression 18 – 20 . It has been reported that overexpression of miR-21 inactivates\nTLR4/NF-kB pathway and thus suppresses myocardial apoptosis \n 18 \n . In our experiments, we found that TLR4 expression was downregulated by miR-21 and\nluciferase reporter assay confirmed that TLR4 was a direct target of miR-21 in endometrial\ncells. In addition, treatment with Exos decreased the expression of TLR4, as well as the\nphosphorylation of p65, a downstream factor of TLR4. In addition, administration of\nADSC-Exos reduced the secretion of LPS-induced IL-1β, TNF-α, and IL-6, but this effect was\nblocked by ectopic expression of TLR4. Taken together, our results indicate the ADSC-Exos\nattenuates LPS-induced inflammation via miR-21/TLR4/Nf-κB signaling. In summary, this study\nreveals that ADSC-derived Exos have an inhibitory effect on LPS-stimulated inflammation in\nendometrial cells both  in vitro  and  in vivo , which is\nmediated by the regulation of miR-21/TLR4/Nf-κB signaling pathway. Our results suggest that\nExos-based therapy may be a promising strategy for the treatment of inflammation-associated\ndiseases, including CE.\n\nClick here for additional data file.\nSupplemental material, sj-jpg-1-cll-10.1177_09636897231173736 for Exosomes From\nAdipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis by Bin Wang,\nLi Li and Ruizhu Yu in Cell Transplantation\nClick here for additional data file.\nSupplemental material, sj-jpg-2-cll-10.1177_09636897231173736 for Exosomes From\nAdipose-Derived Stem Cells Suppress the Progression of Chronic Endometritis by Bin Wang,\nLi Li and Ruizhu Yu in Cell Transplantation","source_license":"CC0","license_restricted":false}